Hereditary fructose intolerance

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:469OMIM:229600E74.1
Who is this for?
Show terms as
8Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary fructose intolerance (HFI), also known as fructose-1,6-bisphosphate aldolase B deficiency or aldolase B deficiency, is a rare inherited metabolic disorder caused by a deficiency of the enzyme aldolase B (fructose-1,6-bisphosphate aldolase) in the liver, kidneys, and small intestine. This enzyme is essential for the metabolism of fructose. When individuals with HFI ingest fructose, sucrose (table sugar), or sorbitol, the accumulation of fructose-1-phosphate in these organs leads to toxic effects including severe hypoglycemia, nausea, vomiting, abdominal pain, and bloating. The disease is caused by pathogenic variants in the ALDOB gene located on chromosome 9q31.1. Symptoms typically first appear in infancy when fructose-containing foods (such as fruits, juices, or sweetened formulas) are introduced into the diet. Acute episodes following fructose ingestion can cause sweating, trembling, confusion, and lethargy due to profound hypoglycemia. Chronic or repeated exposure to fructose can lead to progressive liver damage (hepatomegaly, jaundice, cirrhosis), renal tubular dysfunction (proximal renal tubular acidosis), failure to thrive, and potentially life-threatening liver and kidney failure. Coagulopathy and lactic acidosis may also occur during acute episodes. The cornerstone of treatment is strict lifelong dietary avoidance of fructose, sucrose, and sorbitol. When the diagnosis is made early and the diet is adhered to rigorously, individuals with HFI can lead normal, healthy lives with an excellent prognosis. Many affected individuals develop a natural aversion to sweet foods. Diagnosis is confirmed through molecular genetic testing of the ALDOB gene or, less commonly, by enzymatic assay of liver biopsy tissue. Intravenous glucose administration is the emergency treatment for acute hypoglycemic episodes. Patients should also be cautious about medications and intravenous solutions that may contain fructose, sucrose, or sorbitol as excipients.

Also known as:

Clinical phenotype terms— hover any for plain English:

Reduced circulating aldolase concentrationHP:0012545Episodic hyperhidrosisHP:0001069HypermagnesemiaHP:0002918Abnormality of the coagulation cascadeHP:0003256Reactive hypoglycemiaHP:0012051Chronic hepatic failureHP:0100626
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hereditary fructose intolerance.

View clinical trials →

No actively recruiting trials found for Hereditary fructose intolerance at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary fructose intolerance community →

Specialists

8 foundView all specialists →
SP
Satish SC Rao, MD, PhD
BOULDER, CO
Specialist
PI on 1 active trial
PM
Peter Komericki, MD
Specialist
PI on 1 active trial
CM
Christian Pongracz, MS
Specialist
PI on 1 active trial
CM
C Wilder-Smith, MD
Specialist
PI on 1 active trial
LS
Laurent Servais
Specialist
PI on 1 active trial28 Hereditary fructose intolerance publications
TM
Tappy Luc, MD
Specialist
PI on 1 active trial
JP
Jon Florholmen, MD PhD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary fructose intolerance.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary fructose intoleranceForum →

No community posts yet. Be the first to share your experience with Hereditary fructose intolerance.

Start the conversation →

Latest news about Hereditary fructose intolerance

No recent news articles for Hereditary fructose intolerance.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary fructose intolerance

What is Hereditary fructose intolerance?

Hereditary fructose intolerance (HFI), also known as fructose-1,6-bisphosphate aldolase B deficiency or aldolase B deficiency, is a rare inherited metabolic disorder caused by a deficiency of the enzyme aldolase B (fructose-1,6-bisphosphate aldolase) in the liver, kidneys, and small intestine. This enzyme is essential for the metabolism of fructose. When individuals with HFI ingest fructose, sucrose (table sugar), or sorbitol, the accumulation of fructose-1-phosphate in these organs leads to toxic effects including severe hypoglycemia, nausea, vomiting, abdominal pain, and bloating. The diseas

How is Hereditary fructose intolerance inherited?

Hereditary fructose intolerance follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hereditary fructose intolerance typically begin?

Typical onset of Hereditary fructose intolerance is infantile. Age of onset can vary across affected individuals.

Which specialists treat Hereditary fructose intolerance?

8 specialists and care centers treating Hereditary fructose intolerance are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.